์นด์คํฌํ์ง
์นด์คํฌํ์ง์ **์ํค๋ ธ์นธ๋๊ณ**์ ์ํ๋ ์ ๋งฅ ์ฃผ์ฌ์ฉ ํญ์ง๊ท ์ ์ ๋๋ค. ๋ฐ๋ ค๋๋ฌผ์ ์นจ์ต์ฑ ์์คํ๋ฅด๊ธธ๋ฃจ์ค์ฆ์ด๋ ํ์ข ์ฑ ์นธ๋๋ค ๊ฐ์ผ ์น๋ฃ์ ์ ์ฌ๋ ฅ์ด ์์ผ๋, ํ์ฌ ์์ํ์์์ ์์ ๊ฒฝํ์ ๋งค์ฐ ์ ํ์ ์ ๋๋ค. > **์์ ํ**: ์ํค๋ ธ์นธ๋๊ณ๋ ์ง๊ท ์ ์ธํฌ๋ฒฝ์ ํ์ ์ผ๋ก ํ๊ธฐ ๋๋ฌธ์ 'ํญ์ง๊ท ์ ์ ํ๋์ค๋ฆฐ'์ผ๋ก ๋ถ๋ฆฌ๋ฉฐ ํฌ์ ๋ฅ์ ๋ํ ๋ ์ฑ์ด ๋ฎ์ต๋๋ค. ์ฝ๊ฐ๊ฐ ๋งค์ฐ ๋น์ผ ํธ์ ๋๋ค.
์์ฉ ๊ธฐ์ : Caspofungin acts as a **beta-glucan synthase inhibitor**. It blocks the synthesis of **beta-(1,3)-D-glucan**, an essential structural component found in the cell walls of many filamentous fungi and yeast. **Inhibition of beta-glucan synthase** โ **Depletion of beta-(1,3)-D-glucan** โ **Loss of cell wall structural integrity** โ **Osmotic instability and fungal cell death (fungicidal activity)**.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Invasive aspergillosis or disseminated candidal infections (Investigational) ยท 0.8-1.6 mg/kg ยท IV ยท Not specified ยท Extrapolated from human pediatric studies. Highly investigational in veterinary patients.
- Invasive aspergillosis or disseminated candidal infections (Investigational) ยท 0.8-1.6 mg/kg in patients weighing less than 50 kg and 50-75 mg (total dose) in those weighing more than 50 kg ยท IV ยท Not specified ยท Extrapolated from human pediatric studies. Highly investigational in veterinary patients.
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to caspofungin
- Significant hepatic impairment
์ด์๋ฐ์
- Histamine-mediated signs (rash, facial swelling, pruritus)
- Anaphylaxis
- Intravenous site reactions (pain, redness, phlebitis)
- Hepatic dysfunction
์ฝ๋ฌผ ์ํธ์์ฉ
- Carbamazepine ยท Reduced caspofungin plasma levels
- Cyclosporine ยท Increased caspofungin plasma levels and increased risk of hepatic enzyme increases
- Dexamethasone ยท Reduced caspofungin plasma levels
- Phenytoin ยท Reduced caspofungin plasma levels
- Rifampin ยท Reduced caspofungin plasma levels
๋ชจ๋ํฐ๋ง
- Clinical efficacy
- Periodic liver function tests
- CBC
- Serum electrolytes
๊ณผ์ฉ๋
Limited information is available for veterinary patients. - **Humans**: Dosages of 210 mg (about 3X normal) were well tolerated. - **Primates**: Monkeys receiving 5-8 mg/kg (approx. 4-6X normal) over 5 weeks developed sites of microscopic subcapsular necrosis on their livers.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.